The final diagnosis included vWD type 1 in 8 (8.1%); vWD type 2 in 4 (4%); mild hemophilia A in 4 (4%); vWD type 1 and FXI deficiency in 3 (3%); FV deficiency in 3 (3%); moderate hemophilia A in 2 (2%); hemophilia A carrier in 2 (2%); FVII deficiency in 2 (2%); FXI deficiency in 2 (2%); FX deficiency in 1 (1%); FXII deficiency in 1 (1%); combined FII, VII, IX, X, and FXII deficiency in 1 (1%); combined FV and FVIII deficiency in 1 (1%); combined FVII and FX deficiency in 1 (1%); and hemophilia B carrier in 1 (1%) (Table 1). The gene discussed is F5; the disease is von Willebrand disease 2.